Advertisement

Ads Placeholder
Loading...

Fulgent Genetics, Inc.

FLGT•NASDAQ
Healthcare
Medical - Diagnostics & Research
$16.82
$0.38(2.31%)
U.S. Market opens in 19h 41m

Fulgent Genetics, Inc. (FLGT) Stock Overview

Explore Fulgent Genetics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap525.3M
P/E Ratio-8.55
EPS (TTM)$-1.97
ROE-0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$12.13
3 Months$27.85
1 Year Target$30.95

FLGT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Fulgent Genetics, Inc. (FLGT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $30.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.55 and a market capitalization of 525.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.31%
5-Day Change
3.51%
1-Month Change
21.97%
3-Month Change
-34.27%
6-Month Change
-26.16%
Year-to-Date (YTD) Change
-34.27%
1-Year Change
-1.06%
3-Year Change
-45.69%
5-Year Change
-82.59%
All-Time (Max) Change
83.22%

Contact Information

https://www.fulgentgenetics.com
626 350 0537
4978 Santa Anita Avenue, El Monte, CA, 91780

Company Facts

13,130 Employees
IPO DateSep 29, 2016
CountryUS
Actively Trading

Frequently Asked Questions